
Orbimed Advisors reduced stake in Oric Pharmaceuticals, Inc. By Investing.com
© Reuters. Orbimed Advisors reduced stake in Oric Pharmaceuticals, Inc. On the 24th of March, Orbimed Advisors sold 112 thousand Oric Pharmaceuticals, Inc. (ORIC) shares for $2.8 million at an average price of $24.53 per […]